logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Chronic Lymphocytic Leukemia 1st Ed Michael Hallek Barbara Eichhorst

  • SKU: BELL-10485470
Chronic Lymphocytic Leukemia 1st Ed Michael Hallek Barbara Eichhorst
$ 31.00 $ 45.00 (-31%)

4.4

42 reviews

Chronic Lymphocytic Leukemia 1st Ed Michael Hallek Barbara Eichhorst instant download after payment.

Publisher: Springer International Publishing
File Extension: PDF
File size: 4.21 MB
Author: Michael Hallek, Barbara Eichhorst, Daniel Catovsky
ISBN: 9783030113919, 9783030113926, 3030113914, 3030113922
Language: English
Year: 2019
Edition: 1st ed.

Product desciption

Chronic Lymphocytic Leukemia 1st Ed Michael Hallek Barbara Eichhorst by Michael Hallek, Barbara Eichhorst, Daniel Catovsky 9783030113919, 9783030113926, 3030113914, 3030113922 instant download after payment.

This book summarizes current knowledge on chronic lymphocytic leukemia (CLL), taking into account the most recent research. All aspects are considered, including pathophysiology, clinical presentation, diagnosis, prognosis, treatment, follow-up, and complications and their management. Readers will find important information on the various prognostic markers as well as practical guidance on the use of different diagnostic procedures. A key focus of the book is the changing treatment paradigm in CLL as progress in understanding of pathogenesis and pathophysiology leads to the identification of new potential therapeutic targets. General treatment concepts are clearly described, and it is explained how choice of treatment for CLL depends on stage, age, and performance status as well as specific genetic aberrations. In addition, frontline therapeutic strategies for disease relapse, including allogeneic stem cell transplantation, are reported. Looking beyond CLL, the diagnosis and therapy of T-cell prolymphocytic leukemia and T-cell large granular lymphocyte leukemia, two rare CLL-related entities, are addressed.

Related Products